<DOC>
	<DOCNO>NCT02470845</DOCNO>
	<brief_summary>The aim study investigate efficacy safety Tian Jiu treatment allergic rhinitis compare placebo waitlist patient Hong Kong .</brief_summary>
	<brief_title>Trial Tian Jiu Therapy Allergic Rhinitis</brief_title>
	<detailed_description>This prospective , randomize , single-blinded , controlled trial patient AR . After one-week run-in period , eligible subject randomly assign Tian Jiu group , placebo-control group waitlist-control group . The TJ placebo-control group undergo 4-week treatment one session per week one 4-week post-treatment follow-up . Participants waitlist-control group receive treatment first 4 week require assessed . The total study period nine week .</detailed_description>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<criteria>Positive skin prick test High circulating level allergenspecific IgE antibody detect specific blood test allergy call radioallergosorbent test ( RAST ) ] Clinical history allergen identify Nasal provocation ( test ) Allergic asthma , moderate severe atopic dermatitis , autoimmune disorder , severe chronic inflammatory disease , history anaphylactic reaction , hypersensitivity cetirizine relate drug , specific immunotherapy past 3 year plan next 2 year , pregnancy breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>